Hasil Pencarian - Arif Akyildiz
- Menampilkan 1 - 5 hasil dari 5
-
1
Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine oleh Taha Koray Sahin, Arif Akyildiz, Osman Talha Dogan, Gozde Kavgaci, Deniz Can Guven, Sercan Aksoy
Diterbitkan 2024-06-01
Artikel -
2
Co-Deposition of IgM and C3 May Indicate Unfavorable Renal Outcomes in Adult Patients with Primary Focal Segmental Glomerulosclerosis oleh Safak Mirioglu, Yasar Caliskan, Yasemin Ozluk, Ahmet Burak Dirim, Zulal Istemihan, Arif Akyildiz, Halil Yazici, Aydin Turkmen, Isin Kilicaslan, Mehmet Sukru Sever
Diterbitkan 2019-08-01
Artikel -
3
Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer oleh Feride Yılmaz, Serkan Yaşar, Ömer Denizhan Tatar, Hasan Çağrı Yıldırım, Deniz Can Güven, Arif Akyıldız, Elvin Chalabiyev, Burak Yasin Aktaş, Zafer Arık, Mustafa Erman
Diterbitkan 2024-10-01
Artikel -
4
Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab oleh Hasan Cagri Yildirim, Hicran Anik, Deniz Ates Ozdemir, Rashad Ismayilov, Arif Akyildiz, Kerim Cayiroz, Fahri Ceyhan, Oguzalp Kavruk, Deniz Can Guven, Ozturk Ates, Alp Usubutun, Zafer Arik
Diterbitkan 2024-03-01
Artikel -
5
Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference? oleh Şafak Mirioğlu, Arif Akyıldız, Ali Rıza Uçar, Ömer Uludağ, Yasemin Öztürk, Ahmet Burak Dirim, Erol Demir, Özgür Akın Oto, Işın Kılıçaslan, Yaşar Çalışkan, Halil Yazıcı, Aydın Türkmen, Mehmet Şükrü Sever
Diterbitkan 2023-07-01
Artikel